Correlation Between Prometheus Biosciences and Akero Therapeutics

Can any of the company-specific risk be diversified away by investing in both Prometheus Biosciences and Akero Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prometheus Biosciences and Akero Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Prometheus Biosciences and Akero Therapeutics, you can compare the effects of market volatilities on Prometheus Biosciences and Akero Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prometheus Biosciences with a short position of Akero Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prometheus Biosciences and Akero Therapeutics.

Diversification Opportunities for Prometheus Biosciences and Akero Therapeutics

0.73

Correlation Coefficient

Prometheus Biosciences  Akero Therapeutics

Poor diversification

The 3 months correlation between Prometheus and Akero is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Prometheus Biosciences and Akero Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akero Therapeutics and Prometheus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prometheus Biosciences are associated (or correlated) with Akero Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akero Therapeutics has no effect on the direction of Prometheus Biosciences i.e., Prometheus Biosciences and Akero Therapeutics go up and down completely randomly.

Pair Corralation between Prometheus Biosciences and Akero Therapeutics

If you would invest  2,599  in Akero Therapeutics on September 3, 2024 and sell it today you would earn a total of  611.00  from holding Akero Therapeutics or generate 23.51% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	1.56%
Values	Daily Returns

Prometheus Biosciences  vs.  Akero Therapeutics

Prometheus Biosciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Prometheus Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Prometheus Biosciences is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Akero Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akero Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very unfluctuating basic indicators, Akero Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Prometheus Biosciences and Akero Therapeutics

The main advantage of trading using opposite Prometheus Biosciences and Akero Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prometheus Biosciences position performs unexpectedly, Akero Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akero Therapeutics will offset losses from the drop in Akero Therapeutics' long position.

The idea behind Prometheus Biosciences and Akero Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.